Ocular Therapeutix, Inc.

Ocular Therapeutix, Inc.verified

OCUL

Price:

$5.09

Market Cap:

$756.51M

Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cataract surgery; and DEXTENZA, a dexamethasone ophthalmic insert to treat post-surgical ocular inflammation and pain following ophthalmic surgery, as well as allergic conjunctivitis. It is also developing OTX-TKI, an axitinib intravitreal implant that is in phase 1 clinical trials for the treatment of wet age-related macular degeneration and other retin...[Read more]

Industry

Biotechnology

IPO Date

2014-07-25

Stock Exchange

NASDAQ

Ticker

OCUL

The PE Ratio as of April 2024 (TTM) for Ocular Therapeutix, Inc. (OCUL) is -4.99

According to Ocular Therapeutix, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -4.99. This represents a change of -84.84% compared to the average of -32.91 of the last 4 quarters.

Ocular Therapeutix, Inc. (OCUL) Historical PE Ratio (quarterly & annually)

How has OCUL PE Ratio performed in the past?

The mean historical PE Ratio of Ocular Therapeutix, Inc. over the last ten years is -9.05. The current -4.99 PE Ratio has changed 5.41% with respect to the historical average. Over the past ten years (40 quarters), OCUL's PE Ratio was at its highest in in the March 2021 quarter at 99.99. The PE Ratio was at its lowest in in the September 2023 quarter at -120.75.

Quarterly (TTM)
Annual

Average

-9.05

Median

-4.53

Minimum

-49.28

Maximum

-1.99

Ocular Therapeutix, Inc. (OCUL) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Ocular Therapeutix, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 525.58%

Maximum Annual PE Ratio = -1.99

Minimum Annual Increase = -93.09%

Minimum Annual PE Ratio = -49.28

Quarterly (TTM)
Annual
YearPE RatioChange
2023-4.4129.47%
2022-3.41-93.09%
2021-49.28525.58%
2020-7.88296.19%
2019-1.99-24.38%
2018-2.6329.97%
2017-2.02-56.46%
2016-4.65-15.20%
2015-5.48-37.35%
2014-8.75199.97%

Ocular Therapeutix, Inc. (OCUL) Average PE Ratio

How has OCUL PE Ratio performed in the past?

The current PE Ratio of Ocular Therapeutix, Inc. (OCUL) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-19.03

5-year avg

-13.39

10-year avg

-9.05

Ocular Therapeutix, Inc. (OCUL) PE Ratio vs. Peers

How is OCUL’s PE Ratio compared to its peers?

Ocular Therapeutix, Inc.’s PE Ratio is less than CytomX Therapeutics, Inc. (65.68), less than Assembly Biosciences, Inc. (-1.19), less than Spero Therapeutics, Inc. (3.26), less than Achilles Therapeutics plc (-0.47), less than Terns Pharmaceuticals, Inc. (-3.97), less than Amylyx Pharmaceuticals, Inc. (2.72), less than Acumen Pharmaceuticals, Inc. (-3.76), less than Inozyme Pharma, Inc. (-4.02), less than X4 Pharmaceuticals, Inc. (-2.01), greater than Mereo BioPharma Group plc (-12.28), less than PDS Biotechnology Corporation (-2.34), less than HOOKIPA Pharma Inc. (-0.91), greater than Day One Biopharmaceuticals, Inc. (-7.42),

Build a custom stock screener for Ocular Therapeutix, Inc. (OCUL) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Ocular Therapeutix, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Ocular Therapeutix, Inc. (OCUL) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Ocular Therapeutix, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Ocular Therapeutix, Inc.'s PE Ratio?

How is the PE Ratio calculated for Ocular Therapeutix, Inc. (OCUL)?

What is the highest PE Ratio for Ocular Therapeutix, Inc. (OCUL)?

What is the 3-year average PE Ratio for Ocular Therapeutix, Inc. (OCUL)?

What is the 5-year average PE Ratio for Ocular Therapeutix, Inc. (OCUL)?

How does the current PE Ratio for Ocular Therapeutix, Inc. (OCUL) compare to its historical average?